Clinical Trials Logo

Clinical Trial Summary

The main objective was to evaluate the effect of a nutritional education program for school lunch cooks, aiming to reduce added sugar in schools meals and in their sugar intake.


Clinical Trial Description

Although Brazil is the largest producer and one of the world's largest consumers of sugar, research on sugar consumption is still a weak point among health indicators and there are no population studies to investigate the sugar intake in Brazilian population. Available data have shown reduction in the consumption of refined sugar (-37% between 1996 and 2003) but significant increase in consumption of soft drinks (400%), which constitute the main vehicle for consumption of added sugar. Moreover, studies have shown the adverse effects of excessive consumption of added sugar in dental caries and health, as excess energy intake hence in weight gain. Although several factors are associated with weight gain in adolescents, adults and elders, and several strategies have been released by both Brazil and International Agencies, as the Global Strategy, increased weight gain, particularly in adolescents, has been observed in several countries with large increase in Brazil, justifying specific projects to evaluate which messages, strategies and proposals for intervention would be effective. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01267474
Study type Interventional
Source Rio de Janeiro State University
Contact
Status Completed
Phase Phase 3
Start date March 2007
Completion date December 2007

See also
  Status Clinical Trial Phase
Recruiting NCT05998772 - Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
Completed NCT01046474 - Reducing Beverages and Sugar and Increasing Physical Activity in Public School Adolescents From Brazil Phase 3